HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

INBC 2022

Speaker at Brain Disorders Conference - Thomas J Webster
Keynote Presentation (In-Person)
Thomas J Webster, Interstellar Therapeutics, United States

Nanotechnology has revolutionized numerous industries, particularly medicine. Nanoparticles, nanotubes, drug delivery nanoparticles, and nanotextured neural probes are just several of many examples where nanomedicine is positively impacting neuroscience. This presentation will su [....] » Read More

Speaker at Neuroscience Conference -  Andreas Till
Keynote Presentation (In-Person)
Andreas Till, University of Bonn, Germany

Given the complex etiopathology of neurodegenerative diseases and the limited access to vital human brain cells as suitable research platform, there is an increasing demand of innovative human-specific model systems that help elucidating the causative mechanisms of these disorder [....] » Read More

Speaker at Neuroscience Conference - Ken Ware
Keynote Presentation (Virtual)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

The human central nervous system (CNS) fundamentally does something elegant and simple and is programmed to abide by some simple sets of rules and initial conditions. Fundamentally, the CNS takes in and perceives information coming in from the outside world and responds to it. Ho [....] » Read More

Speaker at Neurology Conferences - Calixto Machado
Keynote Presentation (Virtual)
Calixto Machado, Institute of Neurology and Neurosurgery, Cuba

I was a main expert in the case of Jahi McMath, who was diagnosed with brain death (BD). Nonetheless, ancillary tests performed nine months after the initial brain insult showed conservation of intracranial structures, EEG activity, and autonomic reactivity to the “Mother T [....] » Read More

Speaker at Neuroscience Conference - W S El Masri
Keynote Presentation (Virtual)
W S El Masri, Keele University, United Kingdom

Spontaneous Neurological Recovery is very common in patients with incomplete traumatic spinal cord injuries. This is provided no further mechanical and non-mechanical damage is inflicted onto the injured cord. Currently there is great deal of emphasis on the threats of the Biomec [....] » Read More

Speaker at Brain Disorders Conference - Fulya Turker
Oral Presentation (In-Person)
Fulya Turker, Johns Hopkins University School of Medicine, United States

Proteasome complexes play a critical role in human brain health and disease. Despite enormous effort, a deep understanding of proteasome composition, activity, and abundance in the human brain remains poorly understood. Here, we describe a series of tools that can measure the cat [....] » Read More

Speaker at Neuroscience Conference - Arman John Fijany
Oral Presentation (In-Person)
Arman John Fijany, TCU School of Medicine, United States

Pain is an uncomfortable sensation perceived by the nervous system that can have a variety of different causes. Pain can be seen as a complication of disease, emotional states and even as a standalone pathology. The neuroscience of pain is poorly understood. Multiple levels of co [....] » Read More

Speaker at Neuroscience Conference - Marina Martinez Vargas
Oral Presentation (In-Person)
Marina Martinez Vargas, Baylor College of Medicine, United States

von Willebrand factor (VWF) is a multimeric protein that mediates thromboinflammation and has been linked to traumatic brain injury (TBI), specifically in the pathogenesis of early brain injury. Activated endothelium secretes VWF multimers as long hyperadhesive strings. During TB [....] » Read More

Speaker at Neuroscience Conference - Arman John Fijany
Oral Presentation (In-Person)
Arman John Fijany, TCU School of Medicine, United States

Introduction: While pain is the body’s normal physiological response to tissue damage, it is a significant contributor to worldwide disability as well as physical and psychological distress. These deleterious effects are typically dictated by the duration and intensity of p [....] » Read More

Speaker at Neurology Conferences - Mohammed Elamir
Oral Presentation (In-Person)
Mohammed Elamir, Aviv Clinics, United States

In this presentation, Dr. Mohammed Elamir and Dr. Amir Hadanny will present nearly a decade of research in the use of Hyperbaric Oxygen Therapy (HBOT) to treat chronic symptoms related to Traumatic Brain Injury (TBI) and concussion that can be cognitively and physically debilitat [....] » Read More

Speaker at Brain Disorders Conference - Amir Hadanny
Oral Presentation (In-Person)
Amir Hadanny, Aviv Clinics, United States

In this presentation, Dr. Mohammed Elamir and Dr. Amir Hadanny will present nearly a decade of research in the use of Hyperbaric Oxygen Therapy (HBOT) to treat chronic symptoms related to Traumatic Brain Injury (TBI) and concussion that can be cognitively and physically debilitat [....] » Read More

Speaker at Brain Disorders Conference - Ulrich Sprick
Oral Presentation (In-Person)
Ulrich Sprick, Alexius/Josef Clinic, Germany

Patients with severe therapy-resistant depressive disorders repeatedly pose enormous treatment challenges in psychiatry and neurology. Transcranial pulse stimulation (TPS) as a new non-invasive therapy method could represent a new alternative to standard treatment such as ECT, ma [....] » Read More

Speaker at Neuroscience Conference - Aygun BadaLova
Oral Presentation (In-Person)
Aygun BadaLova, University College London, United Kingdom

One of the most common and prevalent neurodegenerative disorders are Alzheimer's and Dementia which are considered significant causes of mortality and morbidity in today’s society particularly among the elderly population.(Erkkinen, Kim et al. 2018)The etiologic and pat [....] » Read More

Speaker at Neurology Conferences - Lakshmi Sundeep
Oral Presentation (In-Person)
Lakshmi Sundeep, Hindustan Institute of Technology and Science, India

Acute Ischemic Stroke (AIS) is a life-threatening cerebrovascular illness. The cause of AIS is unknown, and treatment options are limited. The study is to find out which genes are expressed in AISs and use that information to guide future research and treatment. The raw datasets [....] » Read More

Speaker at Neurology Conferences - Dell G Mars
Oral Presentation (Virtual)
Dell G Mars, Southeastern Louisiana University School of Nursing, United States

Purpose: The purpose of this qualitative study was to describe the lived experience of African American informal caregivers of family members of Alzheimer’s Disease and Related Dementias (ADRD) in a home environment. Design and Method: This phenomenological descriptive [....] » Read More

Speaker at Brain Disorders Conference - Alsu Zagorulko
Poster Presentation (In-Person)
Alsu Zagorulko, Illinois Center for Neurological and Behavioral Medicine, United States

Introduction: The study was performed to evaluate factors associated with in-hospital mortality, length of stay (LOS), and hospitalization cost among adults with multiple sclerosis (MS). Methods. We used the National Inpatient Sample (2019) to identify adult hospitalizations w [....] » Read More

Speaker at Brain Disorders Conference - Solomon Nittala DO MS
Poster Presentation (In-Person)
Solomon Nittala DO MS, Larkin Community Hospital Palm Springs Campus, United States

Originally described in 1964, progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy with a prevalence of approximately 45% among other parkinsonian-plus syndromes. PSP can be categorized into various phenotypes among which 6% belong to the PSP-frontal predominan [....] » Read More

Speaker at Neurology Conferences -  Elita Delbruck
Poster Presentation (In-Person)
Elita Delbruck, California University of Science and Medicine,, United States

Prion diseases are rare and rapidly progressive neuro-degenerative disorders that are poorly understood. Universally fatal, diagnosis primarily focuses on the excluding other treatable diseases. This case of probable sporadic Creutzfeldt-Jakob Disease (sCJD) in an otherwise healt [....] » Read More

Speaker at Brain Disorders Conference - Luis A Sierra
Poster Presentation (In-Person)
Luis A Sierra, Beth Israel Deaconess Medical Center, United States

Background: A diagnosis of manifest Huntington’s disease (HD) is based primarily on motor symptoms, but early cognitive decline is common in the pre-manifest HD period (preHD). Early symptom detection in HD has important implications for monitoring both disease pr [....] » Read More

Speaker at Neuroscience Conference - Rebecca Lees
Poster Presentation (In-Person)
Rebecca Lees, Guthrie Robert Packer Hospital, United States

Stroke is the number one preventable cause of disability and a leading cause of death in both men and women; rapid assessment and treatment is critical to improve outcomes for patients. Guthrie Robert Packer Hospital received The Joint Commission Primary Stroke Center certificati [....] » Read More

Speaker at Brain Disorders Conference - Gerald W. Grass
Poster Presentation (In-Person)
Gerald W. Grass, Ketamine Research Institute, United States

Objective: Ketamine is recognized as a rapidly acting antidepressant; however, discrepancies exist between the "Efficacy" reported in research studies (70-85%) versus significantly lower "Effectiveness" (18.3-45.5%) reported in community-based settings. To off [....] » Read More

Speaker at Neurology Conferences - Johanna Christina Reiners
Poster Presentation (In-Person)
Johanna Christina Reiners, Ulm University, Germany

Stress is generally defined as a real or interpreted threat to the psychological or physiological integrity of an individual that results in physiological and/or behavioral responses. Threatening stimuli trigger neuronal responses in the brain that cause an immediate adaptive sys [....] » Read More

Speaker at Neurology Conferences - Maral Kasiri
Poster Presentation (In-Person)
Maral Kasiri, University of California, United States

Understanding the relationship between neural activity and voluntary movement provides new insights into understanding the mechanism underlying neural control of movement in both healthy people and those with movement disorders. To investigate the relationship between deep brain [....] » Read More

Speaker at Brain Disorders Conference - Judith Stefanie Schlett
Poster Presentation (In-Person)
Judith Stefanie Schlett, Institute of Physiological Chemistry, Ulm University, Germany

Infl ammaging represents an accepted concept where the immune system shifts to a low-grade chronic pro- infl ammatory state without overt infection upon aging. In the CNS, infl ammaging is mainly driven by glia cells and associated with neurodegenerative processes. White matter d [....] » Read More

Speaker at Brain Disorders Conference - Smaili Rachid
Poster Presentation (In-Person)
Smaili Rachid, University hospital of Tangier- Tétouan-Al Hoceima, France

Background: Creutzfeldt Jakob disease (CJD) is a fatal and rare neurodegenerative disease, It is classified into 3 subgroups: sporadic, genetic and acquired. Sporadic CJD is the most common form, which may be manifested with misleading neuropsychiatric symptoms and resulting in [....] » Read More

Speaker at Neuroscience Conference - Peter J. Facchini
Poster Presentation (In-Person)
Peter J. Facchini, Enveric Biosciences, Canada

The psychedelic compound psilocybin has shown therapeutic benefit in the treatment of several psychiatric diseases. A recent randomized clinical trial conducted at Johns Hopkins Bayview Medical Center demonstrated the efficacy of psilocybin-assisted therapy in the treatment of Ma [....] » Read More

Speaker at Neurology Conferences - Jillian M. Hagel
Poster Presentation (In-Person)
Jillian M. Hagel, 1Enveric Biosciences, Inc, Canada

The skin and paratoid gland secretions of many toads in the Bufonidae family contain several natural products with importance to traditional medicine. Some of these compounds, such the indole amines 5-hydroxy-N,N-dimethyltryptamine (bufotenine) and 5-methoxy-N,N-dimethyltryptamin [....] » Read More

Speaker at Neurology Conferences - Ilhan Yu
Poster Presentation (In-Person)
Ilhan Yu, Nowon eulji university hospital, Korea, Republic of

Background Severe acute respiratory syndrome coronavirus 2 is a coronavirus that has recently appeared, rapidly spreads, and results in coronavirus disease 2019 (COVID-19). Moderna mRNA-1273 and Pfizer-BioNTech BNT162b2 vaccines are among the most widely used and effective va [....] » Read More

Speaker at Brain Disorders Conference - Min Sung Gee
Poster Presentation (In-Person)
Min Sung Gee, Kyung Hee University, Korea, Republic of

Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal cell loss and cognitive impairment are pathological symptoms of Alzheimer’s disease (AD). Regarding these symptoms, resolution of neuroinflammation and inhibition of Aβ-driven pathology m [....] » Read More

Speaker at Brain Disorders Conference - Vildan Tuncbilek
Poster Presentation (In-Person)
Vildan Tuncbilek, Tekirdağ Namık Kemal University, Turkey

Autoimmunity reflects an altered immune status, therefore the presence of more than one disorder is not uncommon. The coexistence of three or more autoimmune diseases in a patient constitutes multiple autoimmune syndrome (MAS). This is an interesting case of a middle-aged female [....] » Read More

Speaker at Neuroscience Conference - Roy G Beran
Keynote Presentation (Virtual)
Roy G Beran, School of Medicine at Griffith University, Australia

There exist many theories regarding the basis of gait inertia and instability for people with Parkinson’s disease (PD). This presentation will use a video to demonstrate an alternative explanation for this occurrence together with a very simple mode of intervention, based o [....] » Read More

Speaker at Neurology Conferences - Georgios Matis
Oral Presentation (Virtual)
Georgios Matis, University Cologne Hospital, Germany

Ziconotide is a synthetic, water-soluble cone snail venom-derived peptide with a molecular weight of 2,639 Daltons. It is a nonopioid analgesic that selectively binds to N-type voltage-sensitive calcium channels on primary nociceptive afferent nerves in the dorsal horn of the spi [....] » Read More

Speaker at Brain Disorders Conference - Brandon Lucke Wold
Oral Presentation (Virtual)
Brandon Lucke Wold, University of Florida, United States

Traumatic brain injury is an important concern in the realm of neurological diseases. At present, our understanding of TBI and its downstream effects both acutely and chronically is limited, although in the past decade, many recent advancements have presented. Current treatment r [....] » Read More

Speaker at Neuroscience Conference - Leya Maliekal
Oral Presentation (Virtual)
Leya Maliekal, Wayne State University School of Medicine, United States

Rubral tremors, or Holmes’ tremors, are a type of movement disorder that appear post-cerebellar/thalamic injury. Optimal treatment approaches for rubral tremors are still being understood and include pharmacological options such as dopamine precursors, anticonvulsants, and [....] » Read More

Speaker at Brain Disorders Conference - Flavia I Spiroiu
Oral Presentation (Virtual)
Flavia I Spiroiu, McMaster University, Canada

BACKGROUND: Despite the potential importance of intolerance of uncertainty (IU) as a transdiagnostic feature that may contribute specifically to social anxiety, empirical data on the construct has been relatively scant and focused largely on Generalized Anxiety Disorder (GAD) and [....] » Read More

Speaker at Neurology Conferences - David Chang
Oral Presentation (Virtual)
David Chang, NHS Hull University Teaching Trust, United Kingdom

Background Venous thromboembolism(VTE) prophylaxis is a recognised part of stroke management in European Stroke Organisation (ESO) guidelines, and a component in the NICE Stroke pathway. The practicalities of the prescribing and application of these modalities whether pharmacolo [....] » Read More

Speaker at Neurology Conferences -  Alice Tebboth
Oral Presentation (Virtual)
Alice Tebboth, East Sussex Healthcare Trust, United Kingdom

Introduction: Cerebral amyloid angiopathy related inflammation (CAARI) is a rare but now increasingly recognised presentation of cerebral amyloid angiopathy (CAA). The clinical presentation is most commonly an acute or subacute onset of cognitive decline, rapidly progressive deme [....] » Read More

Speaker at Brain Disorders Conference - Flavia I Spiroiu
Oral Presentation (Virtual)
Flavia I Spiroiu, McMaster University, Canada

Background. Obsessive-compulsive disorder (OCD) is a common and severe psychiatric disorder. Cognitive behavior therapy (CBT) with exposure and response prevention (ERP) is the gold standard intervention for OCD, but more than 40% of patients with this disorder remain impaired ev [....] » Read More

Speaker at Neuroscience Conference - Cristian Ravariu
Oral Presentation (Virtual)
Cristian Ravariu, Polytechnic University of Bucharest, Romania

To make possible a systemic methodology for the treatment of the neuromuscular pathology, some models must be developed to predict what stimulus can optimal interfere with the system function in order to modify its state. Stripped muscles are part of somatic system - the interact [....] » Read More

Speaker at Brain Disorders Conference - Harinder Jaseja
Oral Presentation (Virtual)
Harinder Jaseja, NIMS University, India

Deep brain stimulation (DBS) of anterior thalamic nucleus (ATN) has established as an effective adjunctive therapy for patients with intractable epilepsy (IE) not suitable for epilepsy brain surgery and/or vagal nerve stimulation. The judicious selection of DBS parameters (DBSPs) [....] » Read More

Speaker at Brain Disorders Conference - Kunal Bhanot
Oral Presentation (Virtual)
Kunal Bhanot, Imperial College London, United Kingdom

The increasing prevalence of blast traumatic brain injury (bTBI) in military personnel has stimulated further research into this field. The neuroendocrine system can be severely affected in blast survivors and anterior pituitary dysfunction has been characterised in soldiers retu [....] » Read More

Speaker at Neuroscience Conference -  Muhesh Taheem
Oral Presentation (Virtual)
Muhesh Taheem, Imperial College London, United Kingdom

The increasing prevalence of blast traumatic brain injury (bTBI) in military personnel has stimulated further research into this field. The neuroendocrine system can be severely affected in blast survivors and anterior pituitary dysfunction has been characterised in soldiers retu [....] » Read More

Speaker at Neurology Conferences - Paul Raj
Oral Presentation (Virtual)
Paul Raj, Jyoti Nivas College, India

Reading is an important skill for mastery in social relationships, academic performance, emotional regulation and most types of work. Reading impairments, one of the most common neurodevelopmental disorders affecting approximately 5-10% of school-going children across languages, [....] » Read More

Speaker at Brain Disorders Conference -  Maria Joao Sacadura
Oral Presentation (Virtual)
Maria Joao Sacadura, Catholic University of Portugal and University of Coimbra, Portugal

The present communication proposes are question how the family and the community are structuring actors in the management of chronic kidney disease; questions the habits and routines of a chronic renal patient based on the neurosciences approach and relates this information to co [....] » Read More

Speaker at Neurology Conferences - Manuel Narváez Peláez
Oral Presentation (Virtual)
Manuel Narváez Peláez, University of Malaga, Spain

Accumulating evidence for Neuropeptide Y (NPY) and galanin (GAL) interaction was shown in various limbic system regions at molecular-, cellular- and behavioral-specific levels. Dysregulation of hippocampal neurogenesis is linked to several neurodegenereative diseases and depressi [....] » Read More

Speaker at Brain Disorders Conference -  Irene Fasciani
Oral Presentation (Virtual)
Irene Fasciani, University of L'Aquila, Italy

Light pollution has recently become a significant global environmental issue. Interestingly, several in vivo approaches and worldwide correlation studies of Parkinson disease onsets have shown to strongly correlate with the distribution of light pollution. In particular it has be [....] » Read More

Speaker at Neuroscience Conference - Julia Souza e Costa
Oral Presentation (Virtual)
Julia Souza e Costa, Anhembi Morumbi University, Brazil

Background: The main reason for neurological disability and death in young adults is traumatic brain injury (TBI), affecting about 60 million people annually. Recovery is directed by the intensity and severity of the lesion, as well as by the dimension of subsequent damage to inf [....] » Read More

Speaker at Neurology Conferences - Ana Beatriz Lima Pedroza
Oral Presentation (Virtual)
Ana Beatriz Lima Pedroza, Anhembi Morumbi University, Brazil

Background: Meningiomas are the most common intracranial tumors, they can occur on any intracranial or spinal dural surfaces and even with benign predominance, are related to neurological deficits and decreased quality of life. Objectives: This paper aims to demonstrate the impo [....] » Read More

Speaker at Neuroscience Conference - Julia Souza e Costa
Oral Presentation (Virtual)
Julia Souza e Costa, Anhembi Morumbi University, Brazil

The number of cases reporting the frequent impact on the nervous system due to SARS-COV-2 infection is increasing and raising justifiable concerns. This impact, usually manifested in more severe cases of the disease, can lead to the most diverse neurological disorders. Among the [....] » Read More

Speaker at Neuroscience Conference - Noor Azzizah Omar
Oral Presentation (Virtual)
Noor Azzizah Omar, National University of Malaysia, Malaysia

Parkinson’s disease (PD) is a multisystem neurodegenerative disorder characterized by heterogenous clinical features associated with Lewy bodies and loss of dopaminergic neurons in the substantia nigra pars compacta. Currently, PD is managed using several disease-modifying [....] » Read More

Speaker at Neuroscience Conference - Nishi M Satish
Oral Presentation (Virtual)
Nishi M Satish, VMMC and Safdarjung Hospital, India

Lebers hereditary optic neuropathy (LHON) is a mitochondrial genetic disease that preferentially causes blindness in young males, prevalence between 1 in 8500 and 1 in 50000. It is an inherited neuropathy characterized by bilateral subacute loss of central vision owing to focal d [....] » Read More

Speaker at Neurology Conferences - Keith Stenning
Oral Presentation (Virtual)
Keith Stenning, University of Edinburgh, Scotland

This is a cautionary tale about disciplinary allergies: a sorry tale from the psychology of reason-ing literature rejecting logic. Understanding a very little logic can be a great boost to empirical investiga-tions. Our goal here is to interest related disciplines in a major shif [....] » Read More

Speaker at Brain Disorders Conference - Seyyedeh Somayyeh Moshir Estekhareh
Oral Presentation (Virtual)
Seyyedeh Somayyeh Moshir Estekhareh, Ferdowsi University of Mashhad, Iran (Islamic Republic of)

Introduction: Selective amygdalohippocampectomy (SA) is an effective treatment for drug-resistant cases of epilepsy due to hippocampal sclerosis (HS). However, its neurocognitive outcomes are inconsistent across previous studies, pointing to potential location-specific confounder [....] » Read More

Speaker at Neuroscience Conference - Ryane Elizabeth Adams
Poster Presentation (Virtual)
Ryane Elizabeth Adams, McGovern Medical School, United States

Introduction: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is defined as an autoimmune disease of the CNS associated with a serological antibody against myelin oligodendrocyte glycoprotein (MOG). MOG is found within the CNS: the optic nerves, brain, and spinal co [....] » Read More

Speaker at Neuroscience Conference - Jacob Saucier
Poster Presentation (Virtual)
Jacob Saucier, University of Sherbrooke, Canada

Background and Objectives: As the COVID-19 pandemic progresses, an increasing amount of research points towards the importance and prevalence of long-term neurocognitive symptoms following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Desig [....] » Read More

Speaker at Neurology Conferences - Beata Lindholm
Poster Presentation (Virtual)
Beata Lindholm, Lund University, Sweden

We have investigated how a de novo cohort of people with Parkinson’s disease (PD) differs in terms of balance and gait function as well as frequency of near falls and falls in comparison to a cohort with mild to moderate PD that has been medicated for several years. Prelimi [....] » Read More

Speaker at Neurology Conferences -  Gabriela Dumitrita Stanciu
Poster Presentation (Virtual)
Gabriela Dumitrita Stanciu, Grigore T. Popa” University of Medicine and Pharmacy, Romania

As one of the major healthcare challenges worldwide, Alzheimer’s disease (AD) is a detrimental brain disorder of a multifactorial nature, with an etiopathogenesis still not completely clear, influenced by epigenetic and genetic variants combined with environmental and lifes [....] » Read More

Speaker at Neurology Conferences - Mariam Al-Umran
Poster Presentation (Virtual)
Mariam Al-Umran, Alfaisal University, Saudi Arabia

Extramedullay hematopoiesis (EMH) is a common compensatory phenomenon to chronic hemolytic anemias. Commonly occurs in the liver, spleen, kidney, lymph nodes and also been reported in skin, adrenal gland, thymus, ovary, paraspinal regions of thorax, pelvic region and the process [....] » Read More

Speaker at Neuroscience Conference - Begüm Bulgurluoglu
Poster Presentation (Virtual)
Begüm Bulgurluoglu , Hisar Schools, Turkey

Approximately 50 million people are addicted to nicotine just in America, worldwide these numbers reach 1.1 billion with 6 million people dying each year from forms of smoking. Even though nicotine is generally known as the “bad guy”, it is important to recognize the [....] » Read More

Speaker at Neuroscience Conference - Marcia Castillo
Poster Presentation (Virtual)
Marcia Castillo, Centro de Salud Fundación Activo 20-30, Dominican Republic

Background: Parkinson’s disease (PD) is usually more prevalent in men than in women, which has been explained in terms of environmental, hormonal and genetic influences, but little has been reported in terms of clinical characteristics among sex. Objective: to analyze mo [....] » Read More

Speaker at Brain Disorders Conference - Zhi-Hao Liu
Poster Presentation (Virtual)
Zhi-Hao Liu, Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, China

Background: ApoE4 is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). Previous studies have shown that innate immune dysfunction induced by ApoE4 plays an important role in brain Aβ deposition and AD. GWAS studies showed that mutations in genes re [....] » Read More

Speaker at Neuroscience Conference - Khadga Raj Aran
Poster Presentation (Virtual)
Khadga Raj Aran, ISF College of Pharmacy, India

Introduction Parkinson’s disease (PD) is a chronic neurodegenerative disorder triggered by degeneration of dopaminergic neurons in substantia nigra pars compacta (SNpc). Low antioxidant level, mitochondrial failure and neuroinflammation are the major pathological mechani [....] » Read More

Speaker at Brain Disorders Conference - Vanessa Veronica
Poster Presentation (Virtual)
Vanessa Veronica, Duta Wacana Christian University, Indonesia

Background. It has long been recognized that inflammation plays a critical role in the pathogenesis of ischemic stroke. However, whether leukocyte count and neutrophil-to-lymphocyte ratio are related to stroke severity and functional outcome is uncertain. Objective. This clini [....] » Read More

Speaker at Neuroscience Conference - TorbjOrn BäckstrOm
Keynote Presentation (Virtual)
TorbjOrn BäckstrOm, UmeA University, Sweden

GABA-ergic transmission is shown to be of importance for regulation of mood, memory, and food intake. The progesterone metabolite allopregnanolone (Allo) is a positive GABAA receptor modulating steroid with potent effects. In humans, disorders like premenstrual dysphoric disorder [....] » Read More

Speaker at Neurology Conferences - Mohammad Abu-Abaa
Oral Presentation (Virtual)
Mohammad Abu-Abaa, Capital Health Internal Medicine Residency, United States

This is a case report of a 45 years old female patient with a past medical history of depression and poor oral intake presented for a single episode of unwitnessed seizure and 3 days of unsteady gait and vertigo. Then she had two episodes of seizure focal and then generalized ton [....] » Read More

Speaker at Neurology Conferences - Geetanjali Rathore
Oral Presentation (Virtual)
Geetanjali Rathore, University of Nebraska Medical Center, United States

Pediatric autoimmune encephalitis (AIE) is emerging to be more common than had previously been thought in children. Even though the underlying pathophysiology is similar, the presentation, antibody types, treatment and outcomes in children are very different from adult autoimmune [....] » Read More

Speaker at Brain Disorders Conference - Benjamin Pinker
Oral Presentation (Virtual)
Benjamin Pinker, Karol Marcinkowski University of Medical Science, Poland

Meningiomas are the most frequent primary tumors arising in the central nervous system. They typically follow a benign course, with an excellent prognosis for grade I lesions through surgical intervention. Although radiotherapy is a good option for recurrent, progressive, or in [....] » Read More

Speaker at Neuroscience Conference - Ana Lilia Rodríguez Villegas
Oral Presentation (Virtual)
Ana Lilia Rodríguez Villegas, Universidad Nacional Autónoma de México, Mexico

This study evaluated the relationship between executive function and adaptive coping strategies (ACS) in healthy adults between the ages of 43 and 52. The participants (n=104) 52 males and 52 females had no history of neurological or psychiatric illnesses or chronic conditions. N [....] » Read More

Speaker at Brain Disorders Conference - Tongtong Li
Oral Presentation (Virtual)
Tongtong Li, Michigan State University, United States

Characterizing the information processing capacity of the human brain is a key challenge in cognitive psychology and neuroscience. Most of the existing research in this area has focused on the capacity limit of short-term working memory, or how well an individual handles informat [....] » Read More

Speaker at Neurology Conferences - Yasemin Tuğçe Yayla
Oral Presentation (Virtual)
Yasemin Tuğçe Yayla, Memorial Sisli Hospital, Turkey

Background: Stroke is a disabling disease due to its functional impairments and complications. In this study, we aimed to examine the clinical profiles, practical outcomes, and complications during rehabilitation of patients hospitalized with stroke. Methods: In this single ce [....] » Read More

Speaker at Neuroscience Conference -  Michelle Herman
Oral Presentation (Virtual)
Michelle Herman, Michelle Herman Speaks, United States

At the age of 32, and 6 months postpartum from having her first child, Michelle walked into the ER with impaired motor skills on the left side of her body, a horrible headache and slurred speech. She was diagnosed with a migraine and discharged. Two days later she had a massive I [....] » Read More

Speaker at Neuroscience Conference - Annapurna Ahuja
Oral Presentation (Virtual)
Annapurna Ahuja, Hazaribag College of Dental Sciences and Hospital, India

Neurodegenerative diseases are a group of progressive disorders that  affect the central nervous system (CNS) such as Alzheimer, Parkinson, and multiple sclerosis. Inflammation plays a critical role in the onset and progression of these injuries. Periodontitis is considered [....] » Read More

Speaker at Neurology Conferences - Almutazballlah Bassam Qablan
Oral Presentation (Virtual)
Almutazballlah Bassam Qablan, Jordan University of Science and Technology, Jordan

Background: Obstructive sleep apnea (OSA) is a disorder caused by the repeated collapse of the upper airway during sleep. It is the most common cause of sleep-related breathing disorder, as OSA can cause loud snoring, daytime fatigue, or more severe problems such as high blood [....] » Read More

Speaker at Brain Disorders Conference - Paulo Henrique Leite Souza
Oral Presentation (Virtual)
Paulo Henrique Leite Souza, Nove de Julho University, Brazil

INTRODUCTION: COVID-19 has different clinical symptoms, with excessive inflammation and cardiovascular changes being common in severe cases. The use of transcutaneous atrial vagus nerve stimulation (taVNS) seems to be a viable treatment for these alterations. OBJECTIVE: To eva [....] » Read More

Speaker at Brain Disorders Conference - Priyanka Sethi
Oral Presentation (Virtual)
Priyanka Sethi, School of Allied Health Sciences, India

Background: Fibromyalgia (FM) is a chronic disorder with persistent manifestation of pain, mood swings, fatigue, depression and attention deficits that affects one’s activity of daily living. Objective: The present study aimed to find prevalence and diagnosis of Fibromya [....] » Read More

Speaker at Neuroscience Conference - Bruany Antoniolli Bianchi
Oral Presentation (Virtual)
Bruany Antoniolli Bianchi, Anhembi Morumbi University, Brazil

Background:  Fat embolism syndrome (FES) is associated with long bone fractures, occurring with a variable frequency of 0,5 to 3,5% after surgical treatment. It affects 90% of open fractures of long bones, being 75% femoral and 19% tibial fractures. Hypoxic - ischemic enceph [....] » Read More

Speaker at Neuroscience Conference - Lama Saad El Din Mahmoud
Oral Presentation (Virtual)
Lama Saad El Din Mahmoud, October 6 University, Egypt

Background/Aims: Parkinsonism characterized by deficits in cognitive functions that affect the motor control. The main aim was to assess the effect of motor learning feedback with augmented cues of motor learning on cognitive functions and motor performance in patients with Parki [....] » Read More

Speaker at Neurology Conferences - Esraa Askar
Oral Presentation (Virtual)
Esraa Askar, Northwell/Hofstra Zucker School of Medicine, United States

Introduction: Transient global amnesia (TGA) involves a sudden onset of anterograde and retrograde amnesia, often accompanied by executive dysfunction, typically lasting up to 24 hours, and not linked to another neurological impairment. Case Presentation: A 52-year-o [....] » Read More

Speaker at Neurology Conferences - Esraa Askar
Oral Presentation (Virtual)
Esraa Askar, Northwell/Hofstra Zucker School of Medicine, United States

Introduction: Early aortic graft infections, which can arise within 4 months of endovascular graft repair, frequently present as high-grade infections. However, late infections can be challenging to detect due to nonspecific symptoms. This case report discusses a late aortic graf [....] » Read More

Speaker at Neurology Conferences - Fareha Khalil
Oral Presentation (Virtual)
Fareha Khalil, University of Limerick, United Kingdom

BACKGROUND AND AIM: Agenesis of the corpus callosum can lead to varied neurodevelopmental outcomes. The prevalence of isolated agenesis of the corpus callosum (iACC) is not known; selection bias in reported series as well as changes in how ACC was diagnosed prenatally, and lac [....] » Read More

Speaker at Brain Disorders Conference - Hamza Islam
Oral Presentation (Virtual)
Hamza Islam, Punjab Medical College, Pakistan

Parkinson’s disease (PD) is a common progressive neurodegenerative movement disorder. The cardinal feature of Parkinson's is neuronal degeneration causing a dopamine deficit in the brain which leads to a host of clinical features in the patient. However, consensus over [....] » Read More

Speaker at Neurology Conferences - Rabia Islam
Oral Presentation (Virtual)
Rabia Islam , Punjab Medical College, Pakistan

Mitral stenosis (MS), a valvular heart disease, is defined by the narrowing of the mitral valve orifice. The common risk factors for stroke include mitral annular calcification (MAC), diabetes mellitus (DM), male gender, hypertension (HTN), hyperlipidemia, and obesity. Endothelia [....] » Read More

Speaker at Neuroscience Conference - Sajjad Saghebdoust
Oral Presentation (Virtual)
Sajjad Saghebdoust, Razavi Hospital, Iran (Islamic Republic of)

Introduction: The effect of systemic tranexamic acid (TXA) administration on blood loss reduction during spine surgeries has been widely published over the past decade. However, topical use of TXA during cervical spine surgery is rarely investigated. We aimed to assess the role o [....] » Read More

Speaker at Neuroscience Conference - Sajjad Saghebdoust
Oral Presentation (Virtual)
Sajjad Saghebdoust, Razavi Hospital, Iran (Islamic Republic of)

Introduction: The thoracolumbar junction represents a transition zone of the spine that leads to a high incidence of fractures. The treatment of burst fractures remains controversial regarding the ideal management. This study assessed the postoperative radiological outcome of tho [....] » Read More

Speaker at Brain Disorders Conference - Neil Gerts
Poster Presentation (In-Person)
Neil Gerts, Los Robles Regional Medical Center, United States

The World Health Organization declared COVID-19 a pandemic in February 2020, and it has affected the life of each and everyone. COVID-19 is designated as severe respiratory syndrome coronavirus 2 (SARS-CoV-2). It causes an acute inflammatory process in the body, which is hypothes [....] » Read More

Speaker at Neuroscience Conference - Shreenal Patel
Poster Presentation (Virtual)
Shreenal Patel, HCA healthcare Houston, United States

Introduction: Neurosarcoidosis is an uncommon manifestation and should be suspected in any patients with sarcoidosis with new neurological symptoms. We present a rare case of probable neurosarcoidosis, which was diagnosed by exclusion and elevated acetylcholinesterase (ACE) le [....] » Read More

Speaker at Neuroscience Conference - Hannah Girgis
Poster Presentation (Virtual)
Hannah Girgis, Aultman Hospital, United States

Neurofibromatosis type 2 (NF2) is a genetic disorder that predisposes individuals to multiple tumors of the nervous system. The most common of these are bilateral vestibular schwannomas; intracranial and spinal meningiomas, and spinal cord ependymomas. The condition is caused by [....] » Read More

Speaker at Neurology Conferences - Joshua Burshtein
Poster Presentation (Virtual)
Joshua Burshtein, Donald and Barbara Zucker School of Medicine at Hofstra / Northwell, United States

Background & Purpose Knowledge surrounding inpatient costs of bacterial meningitis (BM) management is limited. We aimed to explore the financial burden of hospitalization due to BM, including cost trends over time and factors associated with higher costs. Methods We [....] » Read More

Speaker at Brain Disorders Conference - David Galel
Poster Presentation (Virtual)
David Galel, Rosalind Franklin University of Medicine and Science, United States

Multiple Sclerosis (MS) is an autoimmune disease targeting myelin in the central nervous system. Most disease modifying therapies (DMTs) for MS function via immunomodulation by a variety of modalities, some of which are immunosuppressive and some which are not. In this study we c [....] » Read More

Speaker at Brain Disorders Conference - Rebecca Simon
Poster Presentation (Virtual)
Rebecca Simon, Nova Southeastern University, United States

Correct identification and analysis of intracranial masses is of high clinical importance especially when it comes to treating acute illnesses and focal neurological deficits, while preventing further deterioration. We present a rare case of a giant thrombosed aneurysm in the [....] » Read More

Speaker at Neurology Conferences - Mohammad Abu-Abaa
Poster Presentation (Virtual)
Mohammad Abu-Abaa, Capital Health Internal Medicine Residency, United States

A 56 years old female patient presented with a few weeks of persistent nausea, vomiting, watery diarrhea, generalized itching and unintentional weight loss. She denied alcohol intake. Labs showed mild hypercalcemia at 10.6 mg/dl. Abdominal examination was benign. Investigations [....] » Read More

Speaker at Neuroscience Conference -  Patrick Brown
Poster Presentation (Virtual)
Patrick Brown, The University of Queensland, United States

Objective: The purpose of this study was to evaluate the development of clinically diagnosed anxiety or depression within one year following a minor traumatic brain injury (mTBI). Design: A state-wide hospital system (Ochsner Health) retrospective cohort analysis  Settin [....] » Read More

Speaker at Neurology Conferences - Anthia Papazoglou
Poster Presentation (Virtual)
Anthia Papazoglou, Cantonal Hospital Aarau, Switzerland

Background. Optic neuritis and optic neuropathy can cause a reduced color-sensitivity. Therefore, in clinical routine the patient's perception of the red color is tested in order to evaluate the function of the optic nerve. Red desaturation is traditionally tested by presenti [....] » Read More

Speaker at Neurology Conferences - Pourya Bahiraei
Poster Presentation (Virtual)
Pourya Bahiraei, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Background: Behcet's syndrome (BS) is an idiopathic vasculitis disease, which causes a wide spectrum of different focal and systemic symptoms. This review aimed to investigate the neuropsychiatric and cognitive aspects of this syndrome. Method: Using the keywords "psy [....] » Read More

Watsapp